Recombinant human insulin injection
Function and Efficacy
This product is human insulin produced by recombinant DNA technology, and has the same structure and function as natural insulin. It can regulate sugar metabolism, promote the uptake and utilization of glucose by the liver, bones and adipose tissue, promote the conversion of glucose into glycogen and store it in muscles and liver, and inhibit gluconeogenesis, thereby lowering blood sugar.
Ingredients
The main components of this product are: recombinant human insulin.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| INSULINIngredients |
It can regulate sugar metabolism, promote the uptake and utilization of glucose by the liver, bones and adipose tissue, promote the conversion of glucose into glycogen and storage in muscles and liver, and inhibit gluconeogenesis, thereby lowering blood sugar. More |
11061-68-0 | 11 |
Appearance
This product is a colorless clear liquid.
Indication
Type 1 or type 2 diabetes.
Usage and Dosage
1This product is a white suspension and is injected subcutaneously about 1 hour before breakfast and dinner. The specific time is determined by the doctor according to the condition of the patient. 2How to use insulin: Be careful not to let the needle touch any object during use to prevent contamination. If it needs to be mixed with recombinant human insulin injection, it should be done under the guidance of a doctor. Before extracting recombinant human insulin, place the bottle in the palm of your hands and roll it gently until the insulin is a uniform suspension. Use a syringe to extract the required amount of air equal to the low-protamine recombinant human insulin, and inject the air into the recombinant human insulin bottle, and then pull out the needle. Use a syringe to extract the required amount of air equal to the regular recombinant human insulin, and inject the air into the regular recombinant human insulin bottle, then turn the bottle and syringe upside down to extract the correct dose of regular recombinant human insulin.
Adverse Reactions
Literature reports that there are occasional allergic reactions such as local redness, swelling, and itching at the injection site, as well as local subcutaneous lipid hyperplasia. Systemic allergic reactions (systemic rash, shortness of breath, wheezing, decreased blood pressure, rapid pulse, sweating, and severe cases can be life-threatening) have been rarely reported. 1 Lipid malnutrition: Subcutaneous injection of insulin rarely causes lipid atrophy or lipid hyperplasia. If the above situation occurs, you must inform your doctor, and changing the injection technique may improve it. 2 Insulin allergy: ① Local allergic reaction. Occasionally, patients experience redness, swelling, and itching at the injection site, which is called local allergy, which usually disappears within a few days or weeks. In some cases, it may be caused by other reasons and has nothing to do with insulin injection. Such as irritation from skin disinfectants, poor injection techniques, etc. If a local reaction occurs, inform your doctor immediately. ②
Precautions
Patients with a history of insulin allergy are contraindicated.
Drug Interactions
Oral contraceptives, adrenal cortex hormones, thyroid hormone replacement therapy, etc. can cause blood sugar to rise. When used at the same time, the dose of insulin should be increased. Oral hypoglycemic drugs, salicylic acid preparations, sulfonamides and certain antidepressants can cause blood sugar to fall. The dose of insulin should be reduced when used at the same time. Avoid drinking alcoholic beverages.
Storage
Keep tightly closed in a cool place and avoid freezing.
Packaging Specification
10ml: 400 units/tube
Manufacturer
Shenzhen Kexing Biotech Co., Ltd.
-
Founded in:
1993-03-19 -
Address:
Room 4301, Building D1, Kexing Science Park, No. 15, Keyuan Road, Science Park Community, Yuehai Street, Nanshan District, Shenzhen -
Tax NO.:
9144030061884175XP -
Registered Funds:
513.59 million yuan -
Website:
-
Email: